Answers are grounded in this paper and cite their sources.
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.
No takes yet. Share an insight, caveat, or question.
Parvataneni et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: